Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Emotional Intelligence in Patients With Addictive Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03521609
Recruitment Status : Enrolling by invitation
First Posted : May 10, 2018
Last Update Posted : June 6, 2018
Sponsor:
Information provided by (Responsible Party):
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Brief Summary:
The study aims to evaluate the level of emotional intelligence in patients diagnosed with substance use disorder and to evaluate the benefits in emotional skills after a brief intervention based on emotional intelligence.

Condition or disease Intervention/treatment Phase
Substance Use Disorders Behavioral: Emotional intelligence intervention Not Applicable

Detailed Description:
Patients will be recruited by consecutive non-probabilistic sampling in the Addictions Day Hospital of the Addictions Unit of the Hospital de la Santa Creu i Sant Pau in Barcelona. The level of emotional intelligence will be assessed through the following measurement instruments: MSCEIT for the objective emotional intelligence coefficient and the TMMS-24 for the perceived emotional intelligence. Patients will attend 9 sessions of brief group intervention based on emotional intelligence and pre-post intervention differences in participants' TMMS-24 scores will be analyzed

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Emotional Intelligence in Patients With Addictive Disorder
Actual Study Start Date : May 25, 2018
Estimated Primary Completion Date : July 2020
Estimated Study Completion Date : October 2020

Arm Intervention/treatment
Experimental: Emotional Intelligence Intervention
Patient's emotional abilities will be stimulated by means of a brief intervention in a group format (nine sessions). In these sessions we will use both projective and guided-fantasy techniques for the emotional diagnosis, as well as psychoeducational workshops of both emotional education and emotional intelligence development.
Behavioral: Emotional intelligence intervention
Brief group intervention based on emotional intelligence




Primary Outcome Measures :
  1. Change in perceived emotional intelligence, measured with the Spanish version of the Trait Meta-Mood Scale (Fernandez-Berrocal, Extremera & Ramos, 2004). [ Time Frame: Changes from baseline scores at 2-months scores ]
    The Trait Meta-Mood Scale (TMMS-24) is a 24-item self-report instrument with three subscales measuring three key aspects of perceived emotional intelligence: Attention, Clarity and Repair. Each of these three subscales consists of eight items with a 5-point Likert response format (ranging from 1 to 5). Subscale total scores are obtained by summing responses to all items and thus range from 8 to 40, with higher scores indicating greater level of the characteristic assessed.

  2. Score on an ability measure of emotional intelligence, the Spanish version of the Mayer-Salovey-Caruso Emotional Intelligence Test (Extremera & Fernández-Berrocal, 2016). [ Time Frame: Pre-intervention only ]
    The Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT) consists of 141 items that yield an overall emotional intelligence (EI) score and two EI area scores: the Experiential EI and Strategic EI scores. The aforementioned scores have a mean of 100 and a standard deviation of 15, with higher scores indicating greater emotional intelligence.


Secondary Outcome Measures :
  1. Change in self-esteem, measured with the Spanish version of the Rosenberg Self-Esteem Scale (Martin-Albo, Núñez, Navarro & Grijalvo, 2007). [ Time Frame: Changes from baseline scores at 2-months scores ]
    The Rosenberg Self-Esteem Scale (RSES) is a self-report measure of global self-esteem. It consists of ten items with a 4-point Likert response format (ranging from 1 to 4). The RSES total score is obtained by summing responses to all items and thus ranges from 10 to 40, with higher scores indicating greater self-esteem.

  2. Change in subjective happiness, measured with the Spanish version of the Subjective Happiness Scale (Extremera & Fernández-Berrocal, 2013). [ Time Frame: Changes from baseline scores at 2-months scores ]
    The Subjective Happiness Scale (SHS) is a self-report measure of global subjective happiness. It consists of four items with a 7-point Likert response format (ranging from 1 to 7). The SHS total score is obtained by averaging responses to all items and thus ranges from 1 to 7, with higher scores indicating greater happiness.

  3. Change in life satisfaction, measured with the Spanish version of the Satisfaction with Life Scale (Vásquez, Duque & Hervás, 2013). [ Time Frame: Changes from baseline scores at 2-months scores ]
    The Satisfaction with Life Scale (SWLS) is a self-report measure of life satisfaction. It consists of five items with a 7-point Likert response format (ranging from 1 to 7). The SWLS total score is obtained by summing responses to all items and thus ranges from 5 to 35, with higher scores indicating greater life satisfaction.

  4. Change in anxiety levels, measured with the Spanish version of the State-Trait Anxiety Inventory - State subscale (Spielberger, Gorsuch & Lushene, 2011). [ Time Frame: Changes from baseline scores at 2-months scores ]
    The State-Trait Anxiety Inventory - State subscale (STAI-S) is a self-report measure of state anxiety. It consists of 20 items with a 4-point Likert response format (ranging from 0 to 3). The STAI-S total direct score is obtained by summing responses to all items and thus ranges from 0 to 60, with higher scores indicating greater levels of state anxiety.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Substance Use Disorder (DSM-5)
  • 18 to 80 years old

Exclusion Criteria:

  • Presence of severe psychopathological alteration (including severe intoxication)
  • Inability to understand the Spanish language or difficulties writing or reading

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03521609


Locations
Layout table for location information
Spain
Santa Creu i Sant Pau Hospital
Barcelona, Spain, 08025
Sponsors and Collaborators
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Investigators
Layout table for investigator information
Principal Investigator: Seyla De Francisco Prófumo, RN Fundació de Gestió Snitària de l'Hospital de la Santa Creu i Sant Pau

Layout table for additonal information
Responsible Party: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
ClinicalTrials.gov Identifier: NCT03521609     History of Changes
Other Study ID Numbers: IIBSP-INT-2017-106
First Posted: May 10, 2018    Key Record Dates
Last Update Posted: June 6, 2018
Last Verified: June 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders